EichorEICHOR
Condition: Melanocortin Obesity Syndrome Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Melanocortin Obesity Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Atomoxetine in Melanocortin Obesity Syndrome
Phase 2 · 3 location(s) · Icahn School of Medicine at Mount Sinai · NCT06899178Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
Phase 4 · 1 location(s) · Tom Hühne · NCT07674290A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Phase 1/Phase 2 · 7 location(s) · Rhythm Pharmaceuticals, Inc. · NCT06239116
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.